Vosoritide for Short Stature in Turner Syndrome

Abroad (travel likely)RecruitingPHASE2

Conditions

Turner Syndrome · Short Stature

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's National Hospital, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Kimberly Boucher, RN) · kboucher@childrensnational.org · 202-476-1403

Study leads

Roopa Kanakatti Shankar, MBBS, MS
Principal Investigator
Children's National Research Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

Growth Hormone Deficiency · Idiopathic Short Stature · Turner Syndrome

Abroad (travel likely)Recruiting

Seoul, South Korea

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Turner Syndrome · Short Stature Homeobox Gene Mutation · Idiopathic Short Stature

Abroad (travel likely)RecruitingPHASE3

Palo Alto, United States · Sacramento, United States

Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

Growth Hormone Deficiency · Turner Syndrome · Chronic Renal Failure

Abroad (travel likely)Recruiting

Seoul, South Korea

Natural History of Noncirrhotic Portal Hypertension

Cystic Fibrosis · Immunologic Deficiency Syndrome · Turner Syndrome

Abroad (travel likely)Recruiting

Bethesda, United States